Coherus Oncology, Inc. (CHRS)
1.41
-0.05
(-3.42%)
USD |
NASDAQ |
Aug 28, 16:00
1.40
-0.01
(-0.71%)
After-Hours: 20:00
Coherus Oncology Market Cap : 217.80M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 217.80M |
| August 27, 2026 | 225.53M |
| August 26, 2026 | 223.98M |
| August 25, 2026 | 211.62M |
| August 24, 2026 | 210.08M |
| August 21, 2026 | 219.35M |
| August 20, 2026 | 203.90M |
| August 19, 2026 | 205.45M |
| August 18, 2026 | 206.99M |
| August 17, 2026 | 177.64M |
| August 14, 2026 | 185.36M |
| August 13, 2026 | 176.10M |
| August 12, 2026 | 180.73M |
| August 11, 2026 | 186.91M |
| August 10, 2026 | 191.54M |
| August 07, 2026 | 196.18M |
| August 06, 2026 | 195.41M |
| August 05, 2026 | 223.98M |
| August 04, 2026 | 228.62M |
| August 03, 2026 | 222.44M |
| July 31, 2026 | 217.45M |
| July 30, 2026 | 226.70M |
| July 29, 2026 | 217.45M |
| July 28, 2026 | 222.07M |
| July 27, 2026 | 225.16M |
| Date | Value |
|---|---|
| July 24, 2026 | 217.45M |
| July 23, 2026 | 220.53M |
| July 22, 2026 | 220.53M |
| July 21, 2026 | 226.70M |
| July 20, 2026 | 218.99M |
| July 17, 2026 | 215.90M |
| July 16, 2026 | 214.36M |
| July 15, 2026 | 222.07M |
| July 14, 2026 | 223.62M |
| July 13, 2026 | 226.70M |
| July 10, 2026 | 237.50M |
| July 09, 2026 | 251.37M |
| July 08, 2026 | 254.46M |
| July 07, 2026 | 257.54M |
| July 06, 2026 | 240.58M |
| July 02, 2026 | 223.62M |
| July 01, 2026 | 222.07M |
| June 30, 2026 | 215.90M |
| June 29, 2026 | 223.62M |
| June 26, 2026 | 231.33M |
| June 25, 2026 | 228.24M |
| June 24, 2026 | 234.41M |
| June 23, 2026 | 225.16M |
| June 22, 2026 | 228.24M |
| June 18, 2026 | 228.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enanta Pharmaceuticals, Inc. | 396.03M |
| ACADIA Pharmaceuticals, Inc. | 5.011B |
| Alnylam Pharmaceuticals, Inc. | 31.71B |
| Anika Therapeutics, Inc. | 282.38M |
| Savara, Inc. | 1.080B |
Market Cap Related Metrics
| PS Ratio | 3.653 |
| Price to Book Value | 3.58 |
| Price | 1.41 |
| Earnings Yield | -72.43% |